Meeting Overview - The fifth meeting of the Supervisory Board of Shenzhen Changliang Technology Co., Ltd. was convened on August 10, 2025, and held on August 14, 2025, with all three supervisors participating, meeting legal requirements [1][2]. Supervisory Board Resolutions - The Supervisory Board approved the 2025 Half-Year Report and its summary, confirming that the report accurately reflects the company's actual situation without any false records or misleading statements [1][2]. - The Supervisory Board reviewed the special report on the storage and use of raised funds for the first half of 2025, concluding that the company complied with relevant regulations and that the report accurately reflects the situation without any violations [2][3]. - The decision to use idle raised funds and self-owned funds for cash management was deemed compliant with regulations, aimed at improving fund efficiency and returns for the company and shareholders, without harming the interests of minority shareholders [3][4].

Core Points - The report details the fundraising and usage status of Shenzhen Xinhau Optoelectronics Technology Co., Ltd. for the first half of 2025, ensuring compliance with relevant regulations and accurate disclosure of information [1][4][5] Fundraising Overview - The company raised a total of RMB 1,976 million by issuing 20 million new shares at a price of RMB 98.80 per share, with a net amount of RMB 1,895 million after deducting issuance costs [1][3] - The company has established a special account system for the management of the raised funds [1][4] Fund Usage - As of June 30, 2025, the company has used RMB 56.93 million of the raised funds, primarily for the electronic product glass protective screen project [10][12] - The company has temporarily used RMB 28.85 million of idle raised funds to supplement working capital, with plans to return the funds to the special account before the deadline [12][18] - The remaining balance of unused raised funds is RMB 525.17 million, with RMB 455 million allocated for cash management [3][12] Fund Management - The company has signed tripartite and quadripartite supervision agreements with various banks and its sponsor to ensure proper management of the raised funds [5][6] - The company has established a management system for the raised funds in accordance with relevant laws and regulations [4][5] Changes in Fund Investment Projects - The company has made adjustments to the investment amounts and project implementation entities, including increasing the investment in its subsidiary, Enshi Xinhau, for the glass protective screen project [13][14] - The expected completion date for the glass protective screen project has been extended to December 2025 [17] Compliance and Disclosure - The company has complied with all relevant regulations regarding the use and disclosure of raised funds, with no violations reported [15][18]

广东科翔电子科技股份有限公司 截至 2025 年 6 月 30 日止 前次募集资金使用情况鉴证报告 前次募集资金使用情况鉴证报告 众会字(2025)第 10200 号 广东科翔电子科技股份有限公司全体股东： 我们审核了后附的广东科翔电子科技股份有限公司（以下简称"科翔股份"）截至 2025 年 6 月 30 日止的《前次募集资金使用情况的专项报告》。 一、管理层的责任 科翔股份管理层的责任是提供真实、合法、完整的相关资料，按照中国证券监督管理委 员会《监管规则适用指引——发行类第 7 号》及相关规定编制《前次募集资金使用情况的专 项报告》，并保证其内容真实、准确、完整，不存在虚假记录、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对《前次募集资金使用情况的专项报告》发表鉴 证意见。 三、工作概述 我们按照《中国注册会计师其他鉴证业务准则第 3101 号-历史财务信息审计或审阅以外 的鉴证业务》的规定执行了鉴证业务。该准则要求我们计划和实施鉴证工作，以对《前次募 集资金使用情况的专项报告》是否不存在重大错报获取合理保证。在鉴证过程中，我们实施 了包括了解、询问、检查、重新计算， ...

募集资金管理制度 第一章 总则 第一条 为规范美盈森集团股份有限公司（以下简称"公司"）募集资金的存放、使 用和管理，保证募集资金的安全，提高募集资金使用效率，根据《中华人民共和国公司 法》《中华人民共和国证券法》《上市公司证券发行管理办法》《深圳证券交易所股票 上市规则》）（以下简称"股票上市规则"）、《深圳证券交易所上市公司自律监管指 引第 1 号——主板上市公司规范运作》《上市公司募集资金监管规则》等法律、法规及 规范性文件的规定及《美盈森集团股份有限公司章程》（以下简称"公司章程"），结 合公司实际情况，特制定本制度。 第二条 本制度所称募集资金，是指公司通过发行股票或者其他具有股权性质的证券， 向投资者募集并用于特定用途的资金。 本制度所称超募资金是指实际募集资金净额超过计划募集资金金额的部分。 第三条 募集资金到位后，公司应及时办理验资手续，由会计师事务所审验并出具验 资报告。公司对募集资金的管理遵循专户存放、规范使用、如实披露、严格管理的原则。 第四条 公司董事会负责建立健全募集资金管理制度，确保本制度的有效实施，及时 披露募集资金的使用情况，做到募集资金使用的公开、透明和规范。 第五条 公司应 ...

证券代码：001367 证券简称：海森药业 公告编号：2025-037 浙江海森药业股份有限公司 第三届监事会第十三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 具体内容详见公司同日刊登在《证券时报》 《证券日报》 《上海证券报》和巨 （公告编号：2025- 潮资讯网（www.cninfo.com.cn）上的《2025年半年度报告摘要》 表决情况：3票同意，0票反对，0票弃权，审议通过了该议案。 的议案》 经核查，监事会认为：公司2025年半年度募集资金存放与使用情况符合《上 市公司募集资金监管规则》 一、监事会会议召开情况 浙江海森药业股份有限公司（以下简称"公司"）于2025年8月2日以钉钉及 电话通知的方式向全体监事发出了关于召开第三届监事会第十三次会议的通知， 会议于2025年8月13日在公司会议室以现场方式召开。本次会议由监事会主席韦 闯凡先生主持，应出席监事3名，实际出席监事3名，公司董事会秘书列席了本次 会议。本次会议的召集和召开符合《公司法》《公司章程》等有关规定，会议合 法、有效。 二、监事会会议审议情况 经核查，监事会认为 ...

证券代码：300629 证券简称：新劲刚 公告编号：2025-045 广东新劲刚科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、募集资金情况概述 经中国证券监督管理委员会《关于同意广东新劲刚科技股份有限公司向特定 对象发行股票注册的批复》（证监许可〔2023〕2808 号），广东新劲刚科技股 份有限公司（以下简称"公司"）获准向特定对象发行人民币普通股股票 事务所（特殊普通合伙）已于 2023 年 12 月 27 日对本公司向特定对象发行股票 的资金到位情况进行了审验，并出具了容诚验字[2023]510Z0023 号《验资报告》。 二、募集资金专户开立及监管协议签订情况 为规范公司募集资金管理，保护投资者权益，根据有关法律法规及《深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》的规定， 作为募投项目实施主体的全资子公司广东宽普科技有限公司（以下简称"宽普科 技"）根据生产经营情况和募集资金项目投资需要，设立了募集资金专项账户。 乙方：交通银行股份有限公司佛山分行（以下简称乙方） 丙方：民生证券股份有限公司（以下简 ...

Core Viewpoint - The document outlines the fundraising management measures of Yifan Pharmaceutical Co., Ltd., emphasizing the need for strict adherence to regulations and efficient use of raised funds to protect investors' rights and interests [3][4][11]. Summary by Sections General Principles - The purpose of the fundraising management measures is to standardize the management and use of raised funds, improve efficiency, and protect investors' rights [3]. - The term "raised funds" refers to money obtained through the issuance of stocks or other equity-like securities, excluding funds raised for equity incentive plans [3]. - The company must use raised funds prudently and ensure that their use aligns with the commitments made in the issuance application documents [3][4]. Fund Storage - The company is required to open a special account for raised funds, which must be approved by the board of directors, and these funds should not be mixed with other funds [5][6]. - A tripartite supervision agreement must be signed with the underwriter or independent financial advisor and the bank holding the funds within one month of the funds being received [6][7]. Fund Usage - Raised funds should primarily be used for the company's main business and must not be used for high-risk investments or to provide financial assistance to others [8][9]. - If the investment project cannot be completed within the original timeframe, the company must disclose the reasons and the current status of the funds [8][9]. - Any changes in the use of raised funds must be approved by the board and disclosed promptly [9][10]. Supervision and Reporting - The company’s accounting department must maintain detailed records of the use of raised funds, and internal audits should be conducted quarterly [28][29]. - The board must regularly review the status of the raised funds and report any significant discrepancies in usage compared to the planned investment [29][30]. - Independent auditors must verify the annual report on the management and use of raised funds, and any adverse conclusions must be addressed by the board [20][21].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002922 证券简称：伊戈尔 公告编号：2025-064 伊戈尔电气股份有限公司 关于设立募集资金专户并签订三方监管协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于同意伊戈尔电气股份有限公司向特定对象发行股票注册的批 复》（证监许可〔2025〕1509号）同意注册，公司向特定对象发行人民币普通股股票29,563,933股，每 股面值1元，每股发行价13.53元，募集资金总额为400,000,013.49元，扣除各项发行费用8,031,567.64元 （不含税）后的募集资金净额为人民币391,968,445.85元。上述募集资金已于2025年8月11日划至公司指 定账户，经容诚会计师事务所（特殊普通合伙）审验后于2025年8月11日出具了《验资报告》（容诚验 字[2025]518Z0100号）。 二、设立募集资金专户及签订监管协议的情况 2、甲乙双方应当共同遵守《中华人民共和国票据法》《支付结算办法》《人民币银行结算账户管理办 法》 ...

Fundraising Overview - The company raised a total of RMB 455.5322 million through its initial public offering, with a net amount of RMB 390.9331 million after deducting various issuance costs [1][2] - The funds were raised by issuing 20.200986 million shares at a price of RMB 22.55 per share [1] Fund Utilization and Balance - As of December 31, 2022, the company had a remaining balance of RMB 336.43 million in its fundraising account, with RMB 4.70846 million used for projects and RMB 1.69811 million for issuance costs [2] - By December 31, 2023, the remaining balance was RMB 236.3034 million, with RMB 9.35421 million utilized for projects [2] - As of December 31, 2024, the remaining balance was RMB 137.4138 million, with RMB 8.77753 million used for projects [2] - As of June 30, 2025, the remaining balance was RMB 114.5452 million, with RMB 2.37295 million utilized for projects [2] Fund Management - The company has established a fundraising management system to ensure the effective use of funds and protect investor rights [3] - Funds are stored in designated bank accounts, and a tripartite supervision agreement has been signed with the underwriter and banks [3] Project Completion and Remaining Payments - Several projects funded by the raised capital, including the R&D center and marketing network construction, have been completed, with remaining payments totaling RMB 30.1286 million [2][3] - The company has used part of the raised funds to replace self-raised funds for issuance costs, amounting to RMB 4.6433 million [6][11] Idle Fund Management - The company has approved the use of idle funds for cash management, with a limit of RMB 100 million [5][6] - As of June 30, 2025, RMB 42 million of idle funds were allocated for cash management [12]

Core Viewpoint - Guangzhou Duople Electronic Technology Co., Ltd. has established a special account for raised funds to support the "Non-destructive Testing Intelligent Production Base Construction Project" and has signed a tripartite supervision agreement for fund management [1][6]. Fundraising Overview - The company has received approval from the China Securities Regulatory Commission for its initial public offering (IPO), issuing 15.5 million shares at a price of RMB 71.80 per share, raising a total of RMB 1,112.90 million. After deducting issuance costs of approximately RMB 104.98 million, the net amount raised is RMB 1,007.92 million [1][2]. - The funds have been verified by a third party, and a verification report has been issued [1]. Previous Fundraising Account Setup - To ensure proper management and usage of raised funds, the company has established special accounts with several banks and signed tripartite supervision agreements [2][3]. - The total amount stored in previous fundraising accounts is RMB 823.11 million, allocated for various projects including the headquarters building and the non-destructive testing production base [4][5]. New Fundraising Account and Agreement - A new special account has been set up with CITIC Bank for the non-destructive testing project, with a tripartite supervision agreement signed between the company, CITIC Bank, and the sponsor, Great Wall Securities [6][7]. - The agreement stipulates that the special account is exclusively for the designated project, with strict controls on fund withdrawals and usage [7][8]. Agreement Details - The agreement includes provisions for fund management, requiring the company to provide documentation for fund usage and allowing the supervising party to conduct audits and inquiries [9][11]. - The agreement will remain in effect until all funds are utilized and the account is closed, with provisions for dispute resolution [12].